Natural Killer Cells in Asthma

The worldwide prevalence, morbidity, and mortality of asthma have dramatically increased over the last few decades and there is a clear need to identify new, effective, therapeutic and prophylactic strategies. Despite high numbers of NK cells in the lung and their ability to and generate a variety o...

Full description

Bibliographic Details
Main Authors: Khalil eKarimi, Paul eForsythe
Format: Article
Language:English
Published: Frontiers Media S.A. 2013-06-01
Series:Frontiers in Immunology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fimmu.2013.00159/full
id doaj-46112f2c6e7d42089f554dc2a76a110d
record_format Article
spelling doaj-46112f2c6e7d42089f554dc2a76a110d2020-11-25T00:01:27ZengFrontiers Media S.A.Frontiers in Immunology1664-32242013-06-01410.3389/fimmu.2013.0015940271Natural Killer Cells in AsthmaKhalil eKarimi0Paul eForsythe1Universitätsklinikum Hamburg-Eppendorf McMaster UniversityThe worldwide prevalence, morbidity, and mortality of asthma have dramatically increased over the last few decades and there is a clear need to identify new, effective, therapeutic and prophylactic strategies. Despite high numbers of NK cells in the lung and their ability to and generate a variety of immunomodulatory mediators the potential of these cells as therapeutic targets in allergic airway disease has been largely overlooked. The fact that IgE, acting through FcγRIII can activate NK cells resulting in cytokine/chemokine production implies that NK cells may contribute to IgE-mediated allergic responses. Indeed, current evidence suggests that NK cells can promote allergic airway responses during sensitization and ongoing inflammation. In animals models increased NK cells are observed in the lung following antigen challenge, while depletion of NK cells before immunization inhibits allergic airway inflammation. Moreover, in asthmatics NK cell phenotype is altered, and may contribute to promotion of the pro-inflammatory Th2-type environment. Conversely, driving NK cells towards an IFN-γ-secreting phenotype can reduce features of the allergic airway response in animal models. However, we have limited knowledge of the signals that drive the development of distinct subsets and functional phenotypes of NK cells in the lung and thus the role and therapeutic potential of NK cells in the allergic airway remains unclear. Here we review the potentially diverse roles of NK cells in allergic airway disease, identify gaps in current knowledge and discuss the potential of modulating NK cell function as a treatment strategy in asthmahttp://journal.frontiersin.org/Journal/10.3389/fimmu.2013.00159/fullAsthmaairway inflammationNatural Kiiler cellsasthma exacerbationtherapeutic potential of NK cells
collection DOAJ
language English
format Article
sources DOAJ
author Khalil eKarimi
Paul eForsythe
spellingShingle Khalil eKarimi
Paul eForsythe
Natural Killer Cells in Asthma
Frontiers in Immunology
Asthma
airway inflammation
Natural Kiiler cells
asthma exacerbation
therapeutic potential of NK cells
author_facet Khalil eKarimi
Paul eForsythe
author_sort Khalil eKarimi
title Natural Killer Cells in Asthma
title_short Natural Killer Cells in Asthma
title_full Natural Killer Cells in Asthma
title_fullStr Natural Killer Cells in Asthma
title_full_unstemmed Natural Killer Cells in Asthma
title_sort natural killer cells in asthma
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2013-06-01
description The worldwide prevalence, morbidity, and mortality of asthma have dramatically increased over the last few decades and there is a clear need to identify new, effective, therapeutic and prophylactic strategies. Despite high numbers of NK cells in the lung and their ability to and generate a variety of immunomodulatory mediators the potential of these cells as therapeutic targets in allergic airway disease has been largely overlooked. The fact that IgE, acting through FcγRIII can activate NK cells resulting in cytokine/chemokine production implies that NK cells may contribute to IgE-mediated allergic responses. Indeed, current evidence suggests that NK cells can promote allergic airway responses during sensitization and ongoing inflammation. In animals models increased NK cells are observed in the lung following antigen challenge, while depletion of NK cells before immunization inhibits allergic airway inflammation. Moreover, in asthmatics NK cell phenotype is altered, and may contribute to promotion of the pro-inflammatory Th2-type environment. Conversely, driving NK cells towards an IFN-γ-secreting phenotype can reduce features of the allergic airway response in animal models. However, we have limited knowledge of the signals that drive the development of distinct subsets and functional phenotypes of NK cells in the lung and thus the role and therapeutic potential of NK cells in the allergic airway remains unclear. Here we review the potentially diverse roles of NK cells in allergic airway disease, identify gaps in current knowledge and discuss the potential of modulating NK cell function as a treatment strategy in asthma
topic Asthma
airway inflammation
Natural Kiiler cells
asthma exacerbation
therapeutic potential of NK cells
url http://journal.frontiersin.org/Journal/10.3389/fimmu.2013.00159/full
work_keys_str_mv AT khalilekarimi naturalkillercellsinasthma
AT pauleforsythe naturalkillercellsinasthma
_version_ 1725441958194708480